The CNMC has reviewed a draft royal decree regulating the financing procedure of medical products under the National Health System for non-hospitalized patients, aiming to align it with legal requirements similar to those for medications.

The CNMC recommends more specific criteria for including medical products in the healthcare provision system, as well as clearer justifications for distribution and dispensation margins to enhance transparency and legal certainty for operators.

The CNMC can intervene autonomously or upon request from various entities to address concerns related to the financing and pricing of medical products, emphasizing the need for a more balanced and transparent system.